Loading clinical trials...
Loading clinical trials...
A Randomized, Comparative, Double-Blind, Parallel-Group, Multicenter, Monotherapy, Study Of Pregabalin (Lyrica) And Lamotrigine (Lamictal) In Patients With Newly Diagnosed Partial Seizures
Conditions
Interventions
Pregabalin
Lamotrigine
Locations
102
Belgium
Pfizer Investigational Site
Bruges, Belgium
Pfizer Investigational Site
Brussels, Belgium
Pfizer Investigational Site
Leuven, Belgium
Pfizer Investigational Site
Plovdiv, Bulgaria
Pfizer Investigational Site
Sofia, Bulgaria
Pfizer Investigational Site
Sofia, Bulgaria
Start Date
August 1, 2006
Primary Completion Date
December 1, 2009
Completion Date
April 1, 2010
Last Updated
January 28, 2021
NCT00113165
NCT01457989
NCT00141414
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions